1. Home
  2. NKTX vs SHMD Comparison

NKTX vs SHMD Comparison

Compare NKTX & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • SHMD
  • Stock Information
  • Founded
  • NKTX 2015
  • SHMD 1864
  • Country
  • NKTX United States
  • SHMD Germany
  • Employees
  • NKTX N/A
  • SHMD N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • SHMD
  • Sector
  • NKTX Health Care
  • SHMD
  • Exchange
  • NKTX Nasdaq
  • SHMD Nasdaq
  • Market Cap
  • NKTX 123.5M
  • SHMD 102.1M
  • IPO Year
  • NKTX 2020
  • SHMD N/A
  • Fundamental
  • Price
  • NKTX $1.97
  • SHMD $2.10
  • Analyst Decision
  • NKTX Strong Buy
  • SHMD
  • Analyst Count
  • NKTX 5
  • SHMD 0
  • Target Price
  • NKTX $13.50
  • SHMD N/A
  • AVG Volume (30 Days)
  • NKTX 539.6K
  • SHMD 28.7K
  • Earning Date
  • NKTX 11-06-2025
  • SHMD 01-01-0001
  • Dividend Yield
  • NKTX N/A
  • SHMD N/A
  • EPS Growth
  • NKTX N/A
  • SHMD N/A
  • EPS
  • NKTX N/A
  • SHMD N/A
  • Revenue
  • NKTX N/A
  • SHMD $85,165,542.00
  • Revenue This Year
  • NKTX N/A
  • SHMD N/A
  • Revenue Next Year
  • NKTX N/A
  • SHMD N/A
  • P/E Ratio
  • NKTX N/A
  • SHMD N/A
  • Revenue Growth
  • NKTX N/A
  • SHMD N/A
  • 52 Week Low
  • NKTX $1.31
  • SHMD $1.86
  • 52 Week High
  • NKTX $6.49
  • SHMD $4.40
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 41.11
  • SHMD 28.89
  • Support Level
  • NKTX $2.00
  • SHMD $2.11
  • Resistance Level
  • NKTX $2.08
  • SHMD $2.48
  • Average True Range (ATR)
  • NKTX 0.11
  • SHMD 0.22
  • MACD
  • NKTX -0.03
  • SHMD -0.04
  • Stochastic Oscillator
  • NKTX 2.35
  • SHMD 9.33

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

Share on Social Networks: